Better results with continuous glucose monitoring were observed in patients using multiple daily insulin with greater improvement in both glycaemic control ( 7.71 % 0.2 vs 8.58 % 0.2 , p < 0.05 ) and glucose variability and with a marked reduction in the risk of both hypoglycaemia and hyperglycaemia .